id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-261485-0ke5nqy0	Sabir, A. M.	Effects of Anticoagulants and Corticosteroids therapy in patients affected by severe COVID-19 Pneumonia	2020-06-29		.txt	text/plain	4666	303	54	Severe COVID-19 pneumonia group were 63 patients who received methylprednisolone, enoxaparin, antiviral drugs, empirical antibiotics for pneumonia, and standard treatment for comorbidity. Conclusion Early use of a combined anti-inflammatory (corticosteroids and Enoxaparin) and antiviral drugs treatment in patients with moderate to severe COVID-19 pneumonia prevent complications of the disease and improve clinical outcomes. This study evaluates the effectiveness of a combination treatment of anti-inflammatory (corticosteroids and Enoxaparin) and antiviral drugs to treat severe COVID-19 pneumonia. There is one patient in medical ward needs low flow oxygen therapy and methylprednisolone for more than 21 days due to unknown reason or confirmed significant lung disease or infection, but Bactrim was given empirically for possible pneumocystis pneumonia, then improved and discharged home. Extra days of length of stay, and virus clearance time, higher oxygen therapy among patients with comorbidity and moderate COVID-19 pneumonia.	./cache/cord-261485-0ke5nqy0.txt	./txt/cord-261485-0ke5nqy0.txt